series-b
Stage
2
Investors
About
Nucleai is an AI-powered spatial biology company that analyzes tissue images to identify biomarkers for precision oncology, enabling more effective drug development and clinical treatment decisions.
Explore Nucleai's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.